ReBoost

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
ReBoost
Generic name
APIS MELLIFERA, ATROPA BELLADONNA, ZINC GLUCONATE, BAPTISIA TINCTORIA ROOT, ULMUS RUBRA BARK, SULFUR, ZINC ACETATE ANHYDROUS,VINCETOXICUM HIRUNDINARIA ROOT AND CAIRINA MOSCHATA HEART/LIVER
Manufacturer
MediNatura
Product type
HUMAN OTC DRUG
SPL set ID
d26137fa-6916-473a-9518-b0613e5cbcce
SPL ID
8a18d95c-9b99-4421-ba4b-a9ce7026d331
Version
4
Effective date
2022-08-08
Source export date
2026-10-12
Source partition
7
Source file
https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/ff22b88bd32e56cbc369af80345075227138a42b1b3ba9a84f038fd5493a7a47/drug-label-0007-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 01:59:47
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. Consult a health professional promptly. Do not use more than 2 days. This product contains ethanol and should not be inhaled. In rare cases allergic reactions may occur. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. The use of this a by more than one person may spread infection. If symptoms persist or worsen, a health professional should be consulted. Do not use if known sensitivity to ReBoost™ or any of its ingredients exists.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.